397 related articles for article (PubMed ID: 7961113)
21. Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families.
Rossel M; Schuffenecker I; Schlumberger M; Bonnardel C; Modigliani E; Gardet P; Navarro J; Luo Y; Romeo G; Lenoir G
Hum Genet; 1995 Apr; 95(4):403-6. PubMed ID: 7705835
[TBL] [Abstract][Full Text] [Related]
22. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
23. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
[TBL] [Abstract][Full Text] [Related]
24. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
[TBL] [Abstract][Full Text] [Related]
25. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
26. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas.
Chew SL; Lavender P; Jain A; Weber A; Ross RJ; Wass JA; Besser GM; Clark AJ
Clin Endocrinol (Oxf); 1995 Jan; 42(1):17-21. PubMed ID: 7889627
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
Smith DP; Eng C; Ponder BA
J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Ponder BA
Cancer Surv; 1995; 25():195-205. PubMed ID: 8718519
[No Abstract] [Full Text] [Related]
29. RET activation by germline MEN2A and MEN2B mutations.
Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
[TBL] [Abstract][Full Text] [Related]
30. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
31. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
[TBL] [Abstract][Full Text] [Related]
32. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.
Iwashita T; Murakami H; Kurokawa K; Kawai K; Miyauchi A; Futami H; Qiao S; Ichihara M; Takahashi M
Biochem Biophys Res Commun; 2000 Feb; 268(3):804-8. PubMed ID: 10679286
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic activation of the ret protooncogene in thyroid cancer.
Takahashi M
Crit Rev Oncog; 1995; 6(1):35-46. PubMed ID: 8573606
[TBL] [Abstract][Full Text] [Related]
34. Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A.
Wu SL; Chang TC; Huang CN; Chuang LM; Chang TJ
J Formos Med Assoc; 1998 Sep; 97(9):614-8. PubMed ID: 9795529
[TBL] [Abstract][Full Text] [Related]
35. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
[TBL] [Abstract][Full Text] [Related]
36. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.
Miyauchi A; Futami H; Hai N; Yokozawa T; Kuma K; Aoki N; Kosugi S; Sugano K; Yamaguchi K
Jpn J Cancer Res; 1999 Jan; 90(1):1-5. PubMed ID: 10076558
[TBL] [Abstract][Full Text] [Related]
37. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers.
Landsvater RM; de Wit MJ; Zewald RA; Hofstra RM; Buys CH; Ploos van Amstel HK; Höppener JW; Lips CJ
Cancer Res; 1996 Nov; 56(21):4853-5. PubMed ID: 8895732
[TBL] [Abstract][Full Text] [Related]
39. Relationship of familial prominent corneal nerves and lesions of the tongue resembling neuromas to multiple endocrine neoplasia type 2B.
Dennehy PJ; Feldman GL; Kambouris M; O'Malley ER; Sanders CY; Jackson CE
Am J Ophthalmol; 1995 Oct; 120(4):456-61. PubMed ID: 7573303
[TBL] [Abstract][Full Text] [Related]
40. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
